Clinical Trials

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McFall, M.
Right arrow Articles by Lavori, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McFall, M.
Right arrow Articles by Lavori, P. W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Clinical Trials, Vol. 4, No. 2, 178-189 (2007)
DOI: 10.1177/1740774507076923
© 2007 The Society for Clinical Trials

Integrating smoking cessation into mental health care for post-traumatic stress disorder

Miles McFall

Veterans Affairs Puget Sound Health Care System, Seattle, WA, miles.mcfall{at}va.gov, Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA

Andrew J. Saxon

Veterans Affairs Puget Sound Health Care System, Seattle, WA, Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA

Surai Thaneemit-Chen

Veterans Affairs Cooperative Studies Program, VA Palo Alto Health Care System, Palo Alto, CA, USA

Mark W. Smith

Health Economics Resource Center, Department of Veterans Affairs, Menlo Park, CA, Center for Primary Care and Outcomes Research, Stanford University, Stanford, CA, USA

Anne M. Joseph

Minneapolis Veterans Affairs Center for Chronic Disease Outcomes Research, Minneapolis, MN, University of Minnesota, Minneapolis, MN, USA

Timothy P. Carmody

Veterans Affairs Medical Center, San Francisco, and University of California, San Francisco, CA, USA

Jean C. Beckham

Durham Veterans Affairs Medical Center, Durham, NC, VA Mid-Atlantic Region Mental Illness Research, Education, and Clinical Center (MIRECC), and Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, USA

Carol A. Malte

Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA

Julia E. Vertrees

Veterans Affairs Cooperative Studies Program, Clinical Research Pharmacy Coordinating Center, Albuquerque, NM, USA

Kathy D. Boardman

Veterans Affairs Cooperative Studies Program, Clinical Research Pharmacy Coordinating Center, Albuquerque, NM, USA

Philip W. Lavori

Department of Health Research and Policy, Stanford University School of Medicine, Palo Alto, CA

Background Post-traumatic stress disorder (PTSD) is associated with a high prevalence of smoking, heavy cigarette consumption and low cessation rates.

Purpose This manuscript describes the design of a randomized, multisite effectiveness trial to test whether integrating smoking cessation treatment into mental health care (integrated care) improves prolonged abstinence rates among veterans with PTSD, compared with referral to specialized smoking cessation clinics (usual standard of care). Secondary objectives are to assess the cost-effectiveness of integrated care relative to usual standard of care, identify treatment variables that mediate differences between conditions in outcome and determine whether smoking cessation is associated with worsening PTSD and/or depression.

Methods Following randomization, subjects (projected n = 1400) from 10 Veterans Health Administration (VHA) medical centers complete follow-up assessments every three or six months for up to four years. Endpoints include 1-year prolonged abstinence at 18 months postrandomization, 7- and 30-day point-prevalence abstinence and measures of depression, PTSD and economic outcomes.

Results This study is unique in providing the largest scale test of the feasibility and effectiveness of having mental health clinicians implement evidence-based smoking cessation treatment in psychiatric care settings for veterans with PTSD. It incorporates methodological features that are desirable for cessation treatment trials, including: a) assessment of clinically meaningful long-term smoking outcomes; b) a manual guiding delivery of the experimental intervention; c) independent ratings of clinician competence and treatment adherence and d) methods for training clinicians that would enhance implementation of tobacco cessation treatment in large health care systems.

Limitations Use of an exclusively VHA sample with few females limits generalizability. Conclusions The process for meeting challenges in designing this study may provide planning of other large-scale clinical effectiveness trials in tobacco control.

Findings have potential to initiate system-wide change in clinical practice patterns for tobacco cessation treatment involving patients with mental disorders. Clinical Trials 2007; 4: 178—189. http://ctj.sagepub.com


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?